Our Services

 We provide strategic advice on process development, considering the indication and shape of the final therapeutic product from the beginning, ensuring quality, scalability, and flexibility

 We provide guidance on the identification and selection of suitable donor material for therapeutic development and offer donor consent services

 Our team offers guidance on sourcing suitable iPSC lines for the desired indication and population, identifying lines under clinical and commercial licenses 

 Our regulatory affairs and approval services help clients navigate the regulatory landscape and meet the requirements of different jurisdictions, preparing GMP documentation for regulators 

 We provide intellectual property review and licensing services for research, clinical and commercial purposes, helping clients to gain the freedom to operate and understand how that affects the translation strategy

 Our team provides global resource and market analysis services, helping clients understand the demand for PSC/iPSC-derived medicinal products, investment trends, and selecting the best market and indication for their product 

We offer guidance on human leukocyte antigens (HLA) matching and immunomodulation for allogeneic therapies

We help to understand the consequences of the final therapeutic format from the beginning, and provides guidance on  the level of expertise required to administer the therapeutic product and how it contributes to the clinical impact 

We provide guidance on Supply Chain Assessment, 

Supplier Assessment & Redundancy Integration and 

Critical Logistic Attributes

We provide investors with in-depth evaluations of companies' scientific, clinical, manufacturing, business, and promotion strategies to inform and maximize successful investments